CODX - Why Co-Diagnostics GenMark Luminex and Opko Stocks Are Sinking Today
Several stocks of companies that make COVID-19 diagnostic tests were sinking on Thursday following big news from Abbott Laboratories (NYSE: ABT) on Wednesday evening. Abbott announced that it received FDA emergency use authorization (EUA) for a COVID-19 antibody test that costs $5 and provides results within 15 minutes.
Shares of Co-Diagnostics (NASDAQ: CODX) were sliding 11.8% lower as of 11:52 a.m. EDT on Thursday. Luminex (NASDAQ: LMNX) stock was down 11.2%. GenMark Diagnostics (NASDAQ: GNMK) and Opko Health (NASDAQ: OPK) were hit even harder, with their shares falling 16.8% and 20.4%, respectively.
Image source: Getty Images.